Neumora Therapeutics, Inc. Common Stock

NASDAQ:NMRA

Biotechnology

Healthcare
$0.33 -6.21%

-$0.10 today

Market cap
$62.85M
Beta
2.76
P/E (TTM)
-1.2
EPS (TTM)
-$1.24
52W Low $0.72High $3.65

Volume 1.79M

Average 2.02M

Price history

Neumora Therapeutics, Inc. Common Stock SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-87.42%

Period high

$3.59

Period low

$0.33

Latest

$0.33

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KOct 30, 2026Oct 30, 2026
4Aug 21, 2026Aug 21, 2026
4Aug 21, 2026Aug 21, 2026
4Aug 21, 2026Aug 21, 2026
4Aug 21, 2026Aug 21, 2026
4Aug 21, 2026Aug 21, 2026
4Aug 19, 2026Aug 19, 2026
8-KAug 14, 2026Aug 14, 2026
10-QAug 14, 2026Aug 14, 2026
8-KJul 27, 2026Jul 27, 2026
8-KJun 15, 2026Jun 15, 2026
4May 29, 2026May 29, 2026
4May 29, 2026May 29, 2026
8-KMay 29, 2026May 29, 2026
4May 29, 2026May 29, 2026

Competitors

Who does Neumora Therapeutics, Inc. Common Stock compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about NMRA's filings, answered from its disclosures.

What is the latest NMRA filing?

The latest filing shown is 8-K dated Oct 30, 2026.

How many recent filings does NMRA have?

Intrinsic Alpha currently shows 20 recent filings for NMRA.